Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Maharjan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
AAPS Pharmscitech|July 23, 2024
Current Trends and Innovative Approaches in Cancer ImmunotherapyJaechang Kim, Ruby Maharjan, Jonghyuck Park
Journal of Nepal Health Research Council|January 29, 2021
The Efficacy of Rituximab in the Treatment of Membranous NephropathyRuby Maharjan, Jin Wen Wang, Indra Kumar Shrestha
Biorxiv : the Preprint Server for Biology|April 10, 2026
Systemic delivery of drug-free polymeric nanoparticles reprograms innate immunity in a sex-dependent manner after spinal cord injuryJaechang Kim, Irina Kalashnikova, Ruby Maharjan, et al.
International Journal of Nanomedicine|September 10, 2019
Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivativeRudra Pangeni, Saurav Kumar Jha, Ruby Maharjan, et al.
Pharmaceutics|July 25, 2019
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic ChemotherapyRuby Maharjan, Rudra Pangeni, Saurav Kumar Jha, et al.
Biomaterials|January 2, 2022
A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapyRuby Maharjan, Jeong Uk Choi, Seho Kweon, et al.
Drug Delivery|November 3, 2021
Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunityRuby Maharjan, Laxman Subedi, Rudra Pangeni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 17, 2018
Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancerFoyez Mahmud, Ok-Cheol Jeon, Farzana Alam, et al.
Biomaterials|May 31, 2024
Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathwaySeong Jin Park, Seho Kweon, Mudhibadhi Knowledge Moyo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 15, 2020
Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsionJeong Uk Choi, Ruby Maharjan, Rudra Pangeni, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AAPS Pharmscitech|July 23, 2024
Current Trends and Innovative Approaches in Cancer ImmunotherapyJaechang Kim, Ruby Maharjan, Jonghyuck Park
Journal of Nepal Health Research Council|January 29, 2021
The Efficacy of Rituximab in the Treatment of Membranous NephropathyRuby Maharjan, Jin Wen Wang, Indra Kumar Shrestha
Biorxiv : the Preprint Server for Biology|April 10, 2026
Systemic delivery of drug-free polymeric nanoparticles reprograms innate immunity in a sex-dependent manner after spinal cord injuryJaechang Kim, Irina Kalashnikova, Ruby Maharjan, et al.
International Journal of Nanomedicine|September 10, 2019
Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivativeRudra Pangeni, Saurav Kumar Jha, Ruby Maharjan, et al.
Pharmaceutics|July 25, 2019
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic ChemotherapyRuby Maharjan, Rudra Pangeni, Saurav Kumar Jha, et al.
Biomaterials|January 2, 2022
A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapyRuby Maharjan, Jeong Uk Choi, Seho Kweon, et al.
Drug Delivery|November 3, 2021
Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunityRuby Maharjan, Laxman Subedi, Rudra Pangeni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 17, 2018
Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancerFoyez Mahmud, Ok-Cheol Jeon, Farzana Alam, et al.
Biomaterials|May 31, 2024
Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathwaySeong Jin Park, Seho Kweon, Mudhibadhi Knowledge Moyo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 15, 2020
Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsionJeong Uk Choi, Ruby Maharjan, Rudra Pangeni, et al.
Pageof 2